Countries
Institutions
Fields
Rankings
Compare

Search institutions, scholars, countries and publications

Sankore

Named after the University of Sankore in Timbuktu — one of the world’s oldest centres of learning. Every figure here is computed from work-level records in our own graph, never copied from a source’s summary count.

Built from

OpenAlex — works, authorships, subject classification
ROR — institutional identity
ORCID — researcher identity
Crossref — publisher confirmation

Browse

Countries
Institutions
Fields
Rankings
What we cover

Coverage is partial and says so. A country appears with its research output only once its works have been swept; until then the portal shows whatever the graph happens to hold for it and labels it as exactly that.

Combination of metronomic capecitabine and letrozole in metastatic hormone receptor positive, HER2 negative breast cancer: a randomized phase II trial

2024Journal of ChemotherapyJournal

10.1080/1120009x.2024.2342741 Full text2 citations

Authors

6 authors.

Hamdy AzimFirst author
- Cairo University (EG)
as printed: Hamdy A. Azim
Mariam A. SalehCorresponding
- Cairo University (EG)
Passant Essam Eldin
- Cairo University (EG)
Amany Abd-Elhafeez
- Cairo University (EG)
as printed: Ahmed A.M. Abdelhafeez
Mohammed Nezifi Hassan
- Cairo University (EG)
as printed: Mohamed Hassan
Loay KassemSenior author
- Cairo University (EG)

Fields

Assignment is probabilistic — a work belongs to several fields in proportions.

Advanced Breast Cancer Therapieslevel 3 · 1.00
Cancer-related Molecular Pathwayslevel 3 · 0.99
Breast Cancer Treatment Studieslevel 3 · 0.98

Sources

Several sources describing one work is the point — it means the record rests on more than one authority.

openalexseen September 10, 2026
2024 · Journal of Chemotherapy · 2 citations
https://openalex.org/W4398144739

Combination of metronomic capecitabine and letrozole in metastatic hormone receptor positive, HER2 negative breast cancer: a randomized phase II trial · Sankore